Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway

The aim of the present study was to gain insight into the molecular mechanism of gefitinib resistance in non-small cell lung cancer (NSCLC), and demonstrate whether long noncoding RNA (lncRNA) expression signatures differ between gefitinib-sensitive PC9 and gefitinib-resistant PC9 (PC9-R) cell lines...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bing, Jiang, Hong, Wang, Limin, Chen, Xueqin, Wu, Kan, Zhang, Shirong, Ma, Shenglin, Xia, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431660/
https://www.ncbi.nlm.nih.gov/pubmed/28529576
http://dx.doi.org/10.3892/ol.2017.5878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431660/
https://www.ncbi.nlm.nih.gov/pubmed/28529576
http://dx.doi.org/10.3892/ol.2017.5878

Ejemplares similares